Pihlgren Maria, Tougne Chantal, Schallert Nadine, Bozzotti Paola, Lambert Paul-Henri, Siegrist Claire-Anne
Department of Pathology and Pediatrics, World Health Organization Collaborating Center for Vaccinology and Neonatal Immunology, CMU, Rue Michel Servet 1, 1211 Geneva 4, Switzerland.
Vaccine. 2003 Jun 2;21(19-20):2492-9. doi: 10.1016/s0264-410x(03)00052-5.
Unmethylated CpG oligonucleotides (CpG-ODN) increase adult and neonatal primary antibody responses to T-dependent antigens, at yet unidentified stages of antigen-specific B cell differentiation. In adult mice, a single dose of CpG-ODN adjuvanted tetanus toxoid (TT) vaccine markedly enhanced and prolonged splenic TT-specific antibody-secreting-cell (ASC) responses and significantly increased the size of the bone marrow (BM) ASC pool. Surprisingly, this was not associated with changes of germinal center (GC) numbers, size, apoptosis or function. In 1-week-old mice, CpG-ODN also enhanced TT-specific splenic ASC responses, but failed to correct limitations of the GC reaction and of the development of the BM ASC pool.
未甲基化的CpG寡核苷酸(CpG-ODN)在抗原特异性B细胞分化的尚未明确的阶段,可增强成年和新生动物对T细胞依赖性抗原的初次抗体应答。在成年小鼠中,单剂量的CpG-ODN佐剂破伤风类毒素(TT)疫苗显著增强并延长了脾脏中TT特异性抗体分泌细胞(ASC)的应答,并显著增加了骨髓(BM)ASC池的大小。令人惊讶的是,这与生发中心(GC)的数量、大小、凋亡或功能的变化无关。在1周龄小鼠中,CpG-ODN也增强了TT特异性脾脏ASC应答,但未能纠正GC反应和BM ASC池发育的局限性。